Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $337000.0.

  • Nephros' Income towards Parent Company rose 8415.3% to $337000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 26780.97%. This contributed to the annual value of $74000.0 for FY2024, which is 10469.84% up from last year.
  • Per Nephros' latest filing, its Income towards Parent Company stood at $337000.0 for Q3 2025, which was up 8415.3% from $237000.0 recorded in Q2 2025.
  • In the past 5 years, Nephros' Income towards Parent Company registered a high of $579000.0 during Q1 2025, and its lowest value of -$1.9 million during Q3 2022.
  • For the 5-year period, Nephros' Income towards Parent Company averaged around -$313421.1, with its median value being -$295000.0 (2023).
  • In the last 5 years, Nephros' Income towards Parent Company tumbled by 42888.89% in 2022 and then skyrocketed by 42897.73% in 2025.
  • Quarter analysis of 5 years shows Nephros' Income towards Parent Company stood at -$317000.0 in 2021, then soared by 59.31% to -$129000.0 in 2022, then tumbled by 382.17% to -$622000.0 in 2023, then skyrocketed by 158.52% to $364000.0 in 2024, then dropped by 7.42% to $337000.0 in 2025.
  • Its Income towards Parent Company was $337000.0 in Q3 2025, compared to $237000.0 in Q2 2025 and $579000.0 in Q1 2025.